118 related articles for article (PubMed ID: 4905918)
1. Jeryl Lynn Strain Live Attenuated Mumps Virus vaccine in a private pediatric practice.
Nickey LN; Huchton P; McGee WG
South Med J; 1970 Mar; 63(3):306-8. PubMed ID: 4905918
[No Abstract] [Full Text] [Related]
2. Clinical trial of new attenuated mumps virus vaccine (Jeryl Lynn strain): preliminary report.
Pagano JS; Levine RH; Sugg WC; Finger JA
Prog Immunobiol Stand; 1967; 3():196-202. PubMed ID: 4908595
[No Abstract] [Full Text] [Related]
3. Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination.
Weibel RE; Buynak EB; Whitman JE; Leagus MB; Stokes J; Hilleman MR
JAMA; 1969 Mar; 207(9):1667-70. PubMed ID: 5818350
[No Abstract] [Full Text] [Related]
4. Infants' responses to live, attenuated, B level, Jeryl Lynn mumps vaccine.
Wilkins J; Williams FF; Wehrle PF
Am J Dis Child; 1972 Jul; 124(1):66-7. PubMed ID: 5033752
[No Abstract] [Full Text] [Related]
5. Clinical and serological studies in Mexico with live attenuated mumps virus vaccine. (Jerry Lynn strain).
Ramos Alvarez M; Bessudo L
Rev Invest Salud Publica; 1972; 32(2):104-8. PubMed ID: 4584449
[No Abstract] [Full Text] [Related]
6. Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). With observations on the optimal time for testing serologic response.
Brunell PA; Brickman A; Steinberg S
Am J Dis Child; 1969 Sep; 118(3):435-40. PubMed ID: 5812074
[No Abstract] [Full Text] [Related]
7. Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic.
Young ML; Dickstein B; Weibel RE; Stokes J; Buynak EB; Hilleman MR
Pediatrics; 1967 Nov; 40(5):798-803. PubMed ID: 6075651
[No Abstract] [Full Text] [Related]
8. Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine.
Weibel RE; Buynak EB; Stokes J; Hilleman MR
Pediatrics; 1970 May; 45(5):821-6. PubMed ID: 5444402
[No Abstract] [Full Text] [Related]
9. A field with a liver measles-mumps-rubella vaccine.
Walters VW; Miller SA; Jackson JE; Kenny MT
Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
[TBL] [Abstract][Full Text] [Related]
10. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial for evaluating two live attenuated mumps-measles vaccines (Urabe Am 9-Schwarz and Jeryl Lynn-Moraten) in young children.
Popow-Kraupp T; Kundi M; Ambrosch F; Vanura H; Kunz C
J Med Virol; 1986 Jan; 18(1):69-79. PubMed ID: 3511182
[TBL] [Abstract][Full Text] [Related]
12. [Anti-mumps vaccination with live attenuated vaccine in a children's community].
Drouhet V; Celers J; Minvielle A; Lévy-Thierry S
Ann Pediatr (Paris); 1971 Apr; 18(4):277-85. PubMed ID: 5574000
[No Abstract] [Full Text] [Related]
13. Evaluation in young children of the Urabe Am 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain.
Vesikari T; André FE; Simoen E; Florent G; Ala-Laurila EL; Heikkinen A; Kuusinen H; Terho A
Acta Paediatr Scand; 1983 Jan; 72(1):37-40. PubMed ID: 6344550
[TBL] [Abstract][Full Text] [Related]
14. Live, attenuated mumps-virus vaccine.
Hilleman MR; Buynak EB; Weibel RE; Stokes J
N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
[No Abstract] [Full Text] [Related]
15. Live attenuated mumps virus vaccine. II. Early clinical studies.
Stokes J; Weibel RE; Buynak EB; Hilleman MR
Pediatrics; 1967 Mar; 39(3):363-71. PubMed ID: 6018966
[No Abstract] [Full Text] [Related]
16. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population.
Ong G; Goh KT; Ma S; Chew SK
J Infect; 2005 Nov; 51(4):294-8. PubMed ID: 16291282
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic.
Ehrenkranz NJ; Ventura AK; Medler EM; Jackson JE; Kenny MT
Bull World Health Organ; 1975; 52(1):81-5. PubMed ID: 764997
[TBL] [Abstract][Full Text] [Related]
18. [Wide-spread inflammation of the parotid glands (mumps): an underestimated disease. II. Development, use, efficacy and safety of mumps vaccines].
Gałazka A; Kraigher A; Robertson SE
Przegl Epidemiol; 1998; 52(4):401-12. PubMed ID: 10321084
[TBL] [Abstract][Full Text] [Related]
19. [Epidemic parotitis in Italy: results of a 1st vaccination trial].
Midulla M; Tamburello O; Balducci L; Assensio AM; Finocchiaro M; Chicca A; Sabatino G
Ann Sclavo; 1977; 19(2):177-86. PubMed ID: 603264
[TBL] [Abstract][Full Text] [Related]
20. [Community effectiveness of vaccines against infectious parotiditis (mumps). Report of cases].
Limón Mora J; Molina López T; Domínguez Camacho JC
Rev Esp Salud Publica; 1999; 73(4):455-64. PubMed ID: 10575934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
